NuSirt Sciences
Business Services · Tennessee, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3835 Cleghorn Ave Ste 200, Nashville, Te...Phone Number
(615) 810-8191Website
www.nusirt.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NuSirt Sciences
NuSirt Sciences specializes in developing technologies that assess the effects of natural compounds and pharmaceuticals on chronic diseases linked to overnutrition and aging. Their research focuses on therapies for cardiometabolic conditions such as metabolic-associated fatty liver disease, obesity, type 2 diabetes, and hypertension, validated through preclinical studies and clinical trials. The company is currently working on TRIPLN, a combination therapy, and offers LEUSIX, a dietary supplement aimed at supporting cardiometabolic health and weight management. Their intended clients include individuals suffering from these chronic conditions and healthcare professionals seeking effective treatment options.Explore more
NuSirt Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NuSirt Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
NuSirt Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at NuSirt Sciences
Product Launch: Get notified when NuSirt Sciences launches new products
Funding: Get notified immidiatlly once NuSirt Sciences has new funding data
Click to see if NuSirt Sciences had a recent Job posting/layoffs
Check if NuSirt Sciences has recently received funding, and reach out quickly before it becomes old news!
Check out if NuSirt Sciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NuSirt Sciences recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to NuSirt Sciences
Compare insights from companies similar to NuSirt Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NuSirt Sciences
<$5M
1-10
Private
$20.6M
2007
OF
Omar FloresVice President, Clinical Operations & Finance
Company Profile Activity
Activity Insights
NuSirt Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NuSirt Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NuSirt Sciences.
NuSirt Sciences financials insights
Gather financial insights about NuSirt Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series B
$9.1M
Series A
$3.5M
2015
Series C
$6M
2016
Private Equity
$2M
NuSirt Sciences Tech Stack
A closer look at the technologies used by NuSirt Sciences
See more technologies
NuSirt Sciences News & Media
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding NuSirt Sciences
Sign Up For FreeTo access detailed company insights
NuSirt Sciences specializes in developing technologies that assess the effects of natural compounds and pharmaceuticals on chronic diseases linked to overnutrition and aging. Their research focuses on therapies for cardiometabolic conditions such as metabolic-associated fatty liver disease, obesity, type 2 diabetes, and hypertension, validated thro... Read More
